Contact Us

Improving cytologic screening using AI-powered workflow

Paris – Nov 13, 2019 – The application of Convolutional Neural Networks (CNN), an advanced form of Artificial Intelligence (AI), has been widely used in research for automating cytology images. Most of the research to date however, focuses on training the Neutral Networks to classify individual cells or regions of the image.  Recent advances in […]

lire la suite

Keen Eye Raises €1.5 Million from Seventure Partners’ Quadrivium 1 Seed Fund

Paris – Dec 12, 2016 – Keen Eye will finalize the development of its innovative image interpretation platform for laboratories and biomedical research Keen Eye, a company that designs, develops and markets innovative image analysis solutions for research and the medical sector, announced today a 1.5 million fund raising from Seventure Partners’ Quadrivium seed fun. […]

lire la suite

Keen Eye: Fighting Cervical Cancer A Deep Learning Solution to Help the Screening of the Disease

Paris – April 6, 2019  – KEEN EYE laureate of the 7th edition of the Concours d’Innovation Numérique – CIN – « Live Better » category The solution developed by Keen Eye, a French startup specialized in digital technology, has caught the attention of the jury* of the French 7th edition of the Concours d’Innovation […]

lire la suite

Events

JP Morgan / Biotech Showcase San Francisco, Jan 12-15, 2020 – Sylvain Berlemont, CEO of KEEN EYE, will attend JP Morgan. Feel free to send us an invite on the Partnering platform. image : https://drive.google.com/open?id=12cimYN1Qxnzsz-FWEQ-CxZj2LAB8K7W4 EVENTS #2 Biomarker Series Manchester, Feb 18-20, 2020 –  Let’s meet us at Biomarker Series in Manchester to discuss how […]

lire la suite

KEEN EYE and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

PARIS – Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with Iris Pharma, a world-wide leading ophthalmology-focused contract research organization (CRO) that offers preclinical and clinical drug / device development services. The partnership aims at providing Iris Pharma artificial intelligence (AI) applications […]

lire la suite